Postpartum infection, pain and experiences with care among women treated for postpartum hemorrhage in three African countries: A cohort study of women managed with and without condom-catheter uterine balloon tamponade
Open Access
- 8 February 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2), e0245988
- https://doi.org/10.1371/journal.pone.0245988
Abstract
Objective We aimed to determine the risk of postpartum infection and increased pain associated with use of condom-catheter uterine balloon tamponade (UBT) among women diagnosed with postpartum hemorrhage (PPH) in three low- and middle-income countries (LMICs). We also sought women's opinions on their overall experience of PPH care. Methods This prospective cohort study compared women diagnosed with PPH who received and did not receive UBT (UBT group and no-UBT group, respectively) at 18 secondary level hospitals in Uganda, Egypt, and Senegal that participated in a stepped wedge, cluster-randomized trial assessing UBT introduction. Key outcomes were reported pain (on a scale 0-10) in the immediate postpartum period and receipt of antibiotics within four weeks postpartum (a proxy for postpartum infection). Outcomes related to satisfaction with care and aspects women liked most and least about PPH care were also reported. Results Among women diagnosed with PPH, 58 were in the UBT group and 2188 in the no-UBT group. Self-reported, post-discharge antibiotic use within four weeks postpartum was similar in the UBT (3/58, 5.6%) and no-UBT groups (100/2188, 4.6%, risk ratio = 1.22, 95% confidence interval [CI]: 0.45-3.35). A high postpartum pain score of 8-10 was more common among women in the UBT group (17/46, 37.0%) than in the no-UBT group (360/1805, 19.9%, relative risk ratio = 3.64, 95% CI:1.30-10.16). Most women were satisfied with their care (1935/2325, 83.2%). When asked what they liked least about care, the most common responses were that medications (580/1511, 38.4%) and medical supplies (503/1511, 33.3%) were unavailable. Conclusion UBT did not increase the risk of postpartum infection among this population. Women who receive UBT may experience higher degrees of pain compared to women who do not receive UBT. Women's satisfaction with their care and stockouts of medications and other supplies deserve greater attention when introducing new technologies like UBT.Funding Information
- Bill & Melinda Gates Foundation (OPPGH5295)
This publication has 30 references indexed in Scilit:
- Secondary analysis of the WOMAN trial to explore the risk of sepsis after invasive treatments for postpartum hemorrhageInternational Journal of Gynecology & Obstetrics, 2019
- “We know it’s labour pain, so we don’t do anything”: healthcare provider’s knowledge and attitudes regarding the provision of pain relief during labour and after childbirthBMC Pregnancy and Childbirth, 2018
- Incidence of postpartum infection, outcomes and associated risk factors at Mbarara regional referral hospital in UgandaBMC Pregnancy and Childbirth, 2018
- Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and MaliBMJ Open, 2017
- The Mistreatment of Women during Childbirth in Health Facilities Globally: A Mixed-Methods Systematic ReviewPLoS Medicine, 2015
- Use of an intrauterine inflated catheter balloon in massive post‐partum hemorrhage: A series of 52 casesJournal of Obstetrics and Gynaecology Research, 2014
- Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional studyThe Lancet, 2013
- Prevention and treatment of postpartum hemorrhage in low-resource settingsInternational Journal of Gynecology & Obstetrics, 2012
- Cultural Influences on PainReviews in Pain, 2008
- Condom hydrostatic tamponade for massive postpartum hemorrhageInternational Journal of Gynecology & Obstetrics, 2005